If you’re interested in participating in one of our research studies, please fill out the form at the bottom of the page and someone will be in contact with you.
CASCADE – seeking moderate and severe asthmatics
Asthma is a chronic lung disease that causes wheezing, breathlessness, chest tightness, and coughing. Although currently available treatments such as inhaled corticosteroids and bronchodilators can help, many people taking these medications still experience asthma-related symptoms.
The purpose of this study is to help researchers find out if an experimental medication called tezepelumab is a safe and effective treatment for people with asthma. Tezepelumab is designed to work with the body’s immune system to block a molecule associated with inflammation. Tezepelumab is not approved by the United States Food and Drug Administration (FDA).
SIESTA – seeking mild, moderate, and severe asthmatics
Asthma is a chronic condition that causes swelling and inflammation of the airways, making it difficult to breathe. Many people who have asthma also have insomnia (trouble sleeping). Research has shown that insomnia can worsen a person’s asthma and increase the risk of having an asthma attack. The purpose of this study is to help researchers find out if an online behavioral treatment for insomnia can help improve sleep and asthma control in adults with asthma and sleep problems.
AIR (Asthma Institute Research Registry)
Asthma – which affects more than 25 million people in the United states — is a chronic lung disease that that causes swelling and inflammation in the airways, making it hard to breathe. Researchers want to better understand asthma by enrolling people with asthma into the Asthma Institute Research Registry. A research registry is a list of individuals who agree to allow researchers to review and study their medical records, and allow researchers to contact them about future research study opportunities. Many advancements in medicine have resulted from research involving the collection and analysis of the medical record information of patients with a certain disease or condition.
IMSA – seeking mild, moderate, and severe asthmatics
Severe asthma, which affects approximately 5%-10% of asthmatics, is poorly understood and difficult to treat. Researchers think that people with severe asthma may have differences in their lungs and blood, when compared to people with milder forms of asthma or no asthma. The purpose of this study is to look at these differences and find out if how they are related to outcomes over one year.
More Studies Coming Soon!
Research study summaries courtesy of Pitt+Me. For more information about Pitt+Me and to find other University of Pittsburgh research studies, visit their website here.